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INTRODUCTION
The duration and intensity of action of many drugs are largely
determined by the speed at which they are metabolized in the body by
enzymes in liver microsomes (1).

Previous studies have shown that

the activities of drug metabolizing enzymes in liver microsomes are
markedly increased when animals are given various drugs, hormones,
insecticides, and carcinogens�

This increase in activity appears

to represent an increased concentration of enzyme protein and is
referred to as enzyme induction.

Induction of liver microsomal

enzymes leads to an accelerated biotransformation of drugs in vivo.
This results in an· altered duration and intensity of drug action.
It has been reported that steroid hormones a,nd other body constituents
are also substrates of drug metabolizing enzymes in liver microsomes
(l).

This indicates the administration of a hepatic microsomal

enzyme inducer may stimulate the metabolism of natural body
constituents.
Richardson et al. (2) reported that 3-methylcholanthrene
prevents 3'-methyl-4-dimethylaminoazobenzene, a potent carcinogen,
from forming hepatomas in rats when both compounds are fed simulta
neously�

Brown, Miller, and Miller (3) provided an explanation for

this observation when they showed that 3-methylcholanthrene increases
the activity of the liver microsomal enzyme system that metabolizes
aminoazo dyes to non-carcinogenic products.

These investigations

led to further studies of polycyclic hydrocarbons and other compounds
that influence liver microsomal enzyme activity.
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Conney and Burns ( 4) reported that pretreatment of rats with
phenobarbital, barbital; aminopyrine, phenylbutazone, or orphenadrine
enhances the activity of the azo dye demethylase system.

It has been

demonstrated that ·these drugs stimulate the activity of various
other liver microsomal enzymes that metabolize zoxazolamine,
phenylbutazone, hexobarbital, aminopyrine, and 3,4-benzpyrene (5).
More than 200 drugs, insecticides, carcinogens, and othe
_ r chemicals
are known to stimulate the activity of drug metabolizing enzymes
located in the hepatic microsomes (1).
'l'here appears to be a broad range of activity both with respect
to the type of molecule which is able to elicit stimulation of hepatic
microsomal activity and. with respect to the enzyme activities that are
stimulated.

-'!

Inducers are of at least two types, exemplified by

phenobarbital and 3-methylcholanthrene.

Compounds of the pheno-

barbital type stimulate varied pathways of metabolism by liver
microsomal enzymes, includ�ng oxidation and reduction reactions,
glucuronide formation, and de-esterification.

The phenobarbital type

also increases microsomal protein content and alters the morphology
of the agranular endoplasmic reticulum.

Liver microsomes from

phenobarbital treated rats show greater amino acid incorporating
activity when measured in vivo ( 6) and in cell free preparations ( 7),
and exhibit a greater sensitivity to stimulation by poly uridylic acid
( 8) �

The polycyclic aromatic hydrocarbons, ty pified by 3-methyl

cholanthrene, stimulate a more limited group of reactions, do not
affect microsomal protein content, nor do they affect gross morphologic
changes in the agran ular endoplasmic reticulum (1) .
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The two types of inducers differ in the course and intensity of
induction.

On daily administration of,phenobarbital to rats the

maximal increase of enzyme activity (3- to 10-fold) is not reached
for at least 3 days (5).

After injecting polycyclic hydrocarbons

the enzyme activity is more than doubled within 3 to 6 hours and
maximal increases (5- to 10-fold) are observed after 24 hours (9,10) .
The age of the patient is one of the factors that is considered
when a drug is used in therapy.

It is known that the young of man

and animals are more sensitive to certain drugs than adults.

This

greater sensitivity could result from differences in drug metabolizing
enzymes present in liver microsomes.

Studies have shown that adults

have liver microsomal enzyme activity which is several times higher
than the activity present in the embryo (11).·
fouts and Adamson (11) reported that a number of drugs that are
metabolized by enzymes present in liver microsomes of adult rabbits·
are not metabolized by liver microsomes of newborn rabbits.

There is

some activity present two weeks after birth, and at the age of four
weeks activity almost equals the adult level.

include:

The pathways studied

oxidation of hexobarbital, N-dealkylation of aminopyrine,

deamination of amphetamine, hyroxylation of acetanilide, oxidation of
the ring sulfur of chlorpromazine, and the reduction of the nitro
group of p-nitrobenzoic acid.

When the supernatant fraction from·

newborn rabbit livers is added to the reaction vessels containing
adult liver homogenates, the adult enzymes are inhibited in some
cases.

This indicates the possible presence of inhibitors of drug

metabolism in the livers of newborn rabbits.
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Other studies also indicate differences between hepatic micro
somal drug metabolizing enzymes present in newborn and adult animals.
Jondorf et al. (12) reported that liver microsomes of newborn mice
and guinea pigs are deficient in certain drug metabolizing enzymes.
The enzyme systems that N-demethylates arninopyrine, 0-dealkylates
phenacetin, oxidizes hexobarbital, and conjugates phenolphthalein as
the glucuronide can not be demonstrated in newborn guinea pigs.

The

enzyme systems are absent 24 hours after birth but appear during the
�irst week and increase in activity until the animals are about eight
weeks old.

Weatherall (13) reported that pentobarb�tal is more toxic

to newborn than to adult rabbits and rats.

It also produces'a more

sustained pharmacologic effect in newborn animals as measured by loss
of the righting reflex.
ponney et a�. (5) reported that pretreatment of weanling rats
with certain drugs causes a marked increase in the activity of various
enzyme systems in hepatic microsomes.

Inscoe and Axelrod (14) have

shown that benzpyrene injected into newborn rats causes a significant
increase in hepatic microsomal glucuronyl transferase as compared with
untreated litter mates.

They also reported that benzpyrene given to

pregnant rats does not stimulate glucuronyl transferase in the fetus,
though it does cause increased activity in the mother.

Hart --et al.

(15) reported that administration of sodium phenobarbital to pregnant
does or to newborn from untreated does, stimulates hepatic microsomal
drug metabolizing activity present in the newborn.

Concurrent

administration of ethionine blocked this increase in activity.
Crigler and Gold (16) reported that the administration of 15 mg.
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of phenobarbital removed the jaundice from two infants suffering from
congenital nonhemolytic jaundice.

Parallel studies on the metabolism

of salicylate in these children showed a defective capacity to
conjugate glucuronide.
was being administered.

This defect did not exist when phenobarbital
This study suggests that enzyme inducers

given to expectant mothers may have an effect on fetal liver microsomal
enzyme activity.

If enzymes can be induced in this manner it may be

possible to treat congenital metabolic disorders resulting from the
lack of certain enzyme systems by the administration of an enzyme
inducer to the mother before delivery.
The study of Hart et al. (15) indicates that pretreatment of
pregnant rabbits with sodium phenobarbital stimulates microsomal
enzyme activity in the offspring of these animals.

A search of the

literature uncovered no further studies using phenobarbital to
stimulate fetal enzyme activity by pret!eating the mother.

The fact

that there are major differences in the hepatic microsomal enzyme
activities of rats and rabbits along with the observation that
benzpyrene causes no increase in activity in the offspring from
pretreated pregnant rats (14) prompted our investigation of this
phase of enzyme induction.
Fouts and Brodie (17) were the first to report on the enzyme
system which reduces p-nitrobenzoic acid in .liver microsomes.

They

found that this reductive system is located in both the microsomes
and soluble fraction.

It is now known that this system is located

in the microsomes with only a trace of activity present in the soluble
fraction (21, 18).

This system was used in these experiments to

6
determine the effect of sodium phenobarbital on the hepatic
microsomal enzyme activity present in fetal and newborn from
pretreated pregnant females.
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MATERIAL AND METHODS

Sprague-Dawley rats were used in this study.

The animals were

housed in an air-conditioned room (70-75 ° F) and provided with feed
(Purina Laboratory Chow) and water ad libitum.
Sodium phenobarbital (30 mg./kg.) was dissolved in double distilled
water and injected subcutaneously twice daily into pregnant rats. The
injection schedule began approximately five days before delivery and
continued throughout the experimental period.

Some animals were given

less than ten injections prior to delivery because the time of birth
varied from 12 to 24 hours.

A separ�te injection bottle containing

the calculated dose in 0.2 ml. was prepared for each test animal. The
control animals were given 0.2 ml. of double distilled water twice
daily throughout the experimental period.
The activity of the enzyme system which reduces p-nitrobenzoic
acid top-aminobenzoic acid was determined using the method reported
by Fouts and Brodie (17).

During the four to five w eek experimental

period the offspring were sacrificed by decapitation and-their livers
removed.

All subsequent tissue manipulation was carried out at Oto 4

degrees centigrade.

Livers were immediately weighed and homogenized

with a Potter-Elvehjem Teflon-glass homogenizer in

4 parts of 0.2 M

phosphate buffer, pH 7.4, to provide a 20 per cent homogenate.
Duplicate 1.0 ml. (200 mg. of tissue) aliquots of homogenate were
placed in 10 ml. beakers.

The reaction beakers also contained 5.7

micromoles of glucose-6-phosphate, 2.0 micromoles of adenosine
triphosphate (NI1P), 0.25 micromoles of triphosphopyridine nucleotide
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(TPN), 0.3 micromoles of diphosphopyridine nucleotide (DPN), 100
micromoles of nicotinamide, 20.0 micromoles of potassium chloride,
10.0 micromoles of magnesium chloride, 3.0 micromoles of p-nitrobenzoic
acid and sufficient 0.1 M phosphate buffer, pH 7.4, to give a final
volu.�e of 5 ml.

This reaction system is similar to that used by

Mueller and Miller ( 19) .
The reaction beakers were incubated for 2 hours in a Dubnoff
metabolic shaker at 37 ° c. in an atmosphere of nitrogen.

At the end

of the incubation period the reaction was stopped by the addition of
15 ml. of 6.67 per cent trichloroacetic acid.

The precipitated protein

was removed by centrifugation at 3700g for 10 minutes and 5 ml. aliquots
of the supernate were analyzed for p-aminobenzoic acid.
The p-aminobenzoic acid present in the trichloroacetic acid
supernates was diazotized and coupled as described by Bratton and
Marshall ( 20).

One ml. of freshly prepared sodium nitrit� (0. 1%) was

added to the 5 ml. aliquot.

After three minutes 1. 0 ml. of 0.5 per

cent ammonium sulfamate was added to destroy excess nitrite.

The

diazotized product was coupled by adding 1 ml. of 0. 5 per cent
N-(1-Naphthyl)-ethylenediarnine dihydrochloride, allowing fifteen
minutes to complete the reaction.

The colored derivative was

extracted with 10 ml. of isoarnyl alcohol and assayed spectrophoto
metrically on a Spectronic 20 at 540 mu.

The reduction of p-nitobenzoic

acid to p-aminobenzoic acid probably takes place in three stages,
involving the intermediate forma�ion of nitroso and hydroxylamino
compounds.

There is no direct evidence indicating the presence of

these intermediates, but Kamm (21) found that liver microsomes reduce
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nitrosobenzene and phenylhydroxylamine to aniline more rapidly than
The probable pathway for the reduction of nitro

they do nitrobenzene.

groups by microsomal enzymes is the following (17):
--)

Nitro

RN =O

---.>_;)..

Nitroso

>

R-NHOH

Hydroxylanlino

Amino

The reactions involved in for�fng the colored derivative are the
following:
HOOC-o-NH2

NaN0 2

+

p-Aminobenzoic acid

)

Sodium nitrite

'!

+

Diazonium intermediate

n

+

+
+
/; -�CH CH NH
2 2 3
2
2c1-

0

HOOC- '/_\ -N;

Diazonium intermediate

N- (1-Naphthyl)-ethylene
diamine dihydrochloride

Colored
p1:oduct

The following experiments were performed previous to studies
using pregnant rats.
An experiment was conducted to determine the relationship between
tissue levels and the amount of p-aminobenzoic acid formed.

The

amount of p-aminobenzoic acid formed by 100, 150, 200, and 300 milli
_

grams of tissue was determined.

Three reaction vessels for each tissue

level.were prepared using a 20 per cent adult female liv�r homogenate.
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A control containing liver homogenate and all other ingredients except
p-�itrobenzoic acid was also prepared.
are shown in Fig. 1.

The results of this experiment

The results indicate that a di�ect relationship

exists between the amount of tissue used and the amount of p-a.mino
benzoic acid formed.

The 200 mg. tissue level was used in all other

parts of this study to measure the effect of sodium phenobarbital on
the enzyme system which reduces p-nitrobenzoic acid.
A test was performed to determine if the substrate was rate
•limiting.

Seven reaction vessels were prepared using 1 ml. of a 20
0

per cent adult female liver homogenate and the previously listed
ingredients.

Three vessels contained six micromoles of p-nitrobenzoic

acid, three contained three micromoles, and one served as a tissue
blank.

The same amount of p-aminobenzoic acid was formed in all

reaction vessels containing substrate.
_,I

i

This indicates that three

micromoles of p-nitrobenzoic acid is not rate _limiting.

A trial was conducted to determine the point at which the

reaction is complete.
200 mg. of tissue.

Nine reaction vessels were prepared using

Two reaction vessels were removed after 30,

60, 90, 120, 150, and 180 minutes and assayed for p-aminobenzoic acid.
The results of this trial are shown in Fig. 2.

The results indicate

that the reaction is essentially complete in 120 minutes.
An experiment to determine the minimal dose of sodium
phenobarbital capable of stimulating a significant increase in the
activity of the enzyme system which reduces p-nitrobenzoic acid was
conducted.

Five groups, each containing three adult female rats,
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were given sodium phenobarbital, dissolved in double distilled water,
twice a day at different dosage levels.
experiment are presented in Table 1.

The results of this

The administration of sodium

phenobarbital 5 mg. /kg. and 10 mg. /kg. did not significantaly
stimulate p-nitrobenzoic acid reductase activity.

A dose of 20 mg./kg.

twice a day caused a 29 per cent increase while the 30 mg./kg. and

40 mg./kg. dose increased activity by 176 and 243 per cent respectively.
The dose of 30 mg./kg. was used in all subsequent experiments in
this study because it was the minimal c;lose which caused a significant
increase in enzyme activity.

The dose of 40 mg. /kg. stimulatetl the

enzyme activity to a higher level, but also increased the possibility
of causing fetal and newborn sedation.
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TABLE I
EFFECT OF SODIUM PHENOBARBITAL ON THE ACTIVITY
OF THE ENZYME SYSTEM WHICH REDUCES
p-NITROBENZOIC ACID IN THE
ADULT FEMALE RAT�

Deys of
Injection

Enzyme Activity
Per Cent
(micromoles of p-aminobenzoic
of
Control·
(mg. /kg.) acid formed per 200 mg.
tissue per 120 minutes).
Dose

Per Cent
Change
In
Activity

. 25

Control
3

5

.25

100

0

3

10

. 27

104

4

3

20

. 35

129

29

3

30

. 69

276

176

3

40

. 95

34 3

24 3
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RESULTS
Standard p-aminobenzoic acid curve •. An experiment to determine
the relationship between the concentration of p-am�nobenzoic acid
present in a 5 ml. aliquot of the trichloroacetic acid supernate and
the optical density at 540 mu. was conducted.

Reaction vessels

containing the previously listed ingredients and concentrations of
p-aminobenzoic acid ranging from Oto 1.2 micromoles were prepared.
The vessels were incubated for two hours in an atmosphere of nitrogen.
The reaction was then stopped by the addition of trichloroacetjc acid
and 5 ml. aliquot samples were analyzed for p-aminobenzoic acid
content by the previously described method.
experiment are shown in Fig. 3.

The results of this

Each point on the curve represents

the average value obtained from triplicate determinations from three
trials.

The results of this experiment indicate there is a direct

relationship between the concentration of p-aminobenzoic acid and
optical density in the range of Oto 1.2 micromoles.

Enzyme

activity is directly related to the a�ount of p-aminobenzoic acid
formed, therefore, this curve was used to determine the results of
this study.
The influence of sodium phenobarbital on the hepatic microsomal
enzyme system which reduces p-nitrobenzoic acid in newborn and fetal
rats from pretreated pregnant females.

To determine the effect of

sodium phenobarbital pretreatment on newborn and fetal rats three
pregnant animals were given subcutaneous injections of 30 mg./kg.
twice daily beginning approximately five days before delivery and

16
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Standard p-aminobenzoic acid curve. Optical density versus
micromoles of p-aminobenzoic acid present in a 5 ml. aliquot.
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continuing throughout the experimental period.

The offspring were

sacrificed at various intervals and their livers removed.
homogenates were prepared from male and female livers.

Separate

The liver

homogenates were tested for their ability to reduce p-nitrobenzoic
acid to p-aminobenzoic acid.
in Fig.

The results of these tests are presented

4. Each point on the curve represents the average enzyme

activity of groups of six rats.

The level of activity present in

male and female homoge�ates was equal at all times during devel�pment,
therefore, a single curve was prepared.
as units.

Enzyme activity is expressed

One unit equals 0.1 micromole of p-aminobenzoic acid

produced by 200 mg. of tissue in two hours.
The hepatic microsomal enzyme system which reduces p-nitrobenzoic
acid is present 24 hours after birth.

The activity rapidly increases

to 33 per cent of the adult level in 14 days.

The activity is equal

to 75 per cent of the adult level at the age of 22 days and reaches
the adult level at the age of 26 days.

The offspring from sodium

phenobarbital pretreated rats may have a more active p-nitrobenzoic
acid reductase present at birth as indicated by a slightly higher
level of activity during the first three days of life as compared to
offspring from control animals.

This increase in activity is apparently

caused by sodium phenobarbital which reaches the fetus through the
placenta.

Tnere is a definite increase in activity of this system

in offspring from pretreated females as indicated by the increased
rate of development and the higher level of activity reached.

Sodium

phenobarbital in the mrunmillary secretion may be the cause of this

increased activity.
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The influence o� sodium phenobarbital 2,g_ the hepatic microsomal
enzyme system which reduces p-nitrobenzoic acid in newborn rats
receiving phenobarbital through the mother's milk.

To determine the

effect of sodium phenobarbital on newborn receiving this barbiturate
through the mother's milk, female rats were given a dose of 30 mg./kg.
by subcutaneous injection twice daily beginning on the day of delivery
and continuing throughout the experimental period.

The offspring

were sacrificed and their hepatic microsomal enzyme activity determined.

The results of these determinations are also shown in Fig.

4.

The

results indicate that the enzyme system which reduces p-nitrobenzoic
acid in hepatic microsomes was stimulated in the offspring receiving
phenobarbital through the milk.

The enzyme activity is stimulated

to the same extent, but develops at a slower · rate than the activity
present in offspring from rats that were given sodium phenobarbital
during their pregnancy.

20 .

DISCUSSION
This study was undertaken to obtain information on the influence
of sodium phenobarbital on the hepatic microsomal enzyme system which
reduces p-nitrobenzoic acid in fetal and newborn rats from pretreated
females.

The enzyme system in liver microsomes that catalyze the

reduction of p-nitrobenzoic acid exhibited low activity in newborn
rats and developed rapidly to �he adult level in four weeks.

Results

of this study indicate.that the administration of sodium phenobarbital
(30 mg. /kg. ) to pregnant rats twice daily by subcutaneous injection
beginning five days before delivery and continuing throughout· the
experimental period stimulates the rate of development and increases
the level of p-nitrobenzoic acid reductas e twofold.

Offspring from

pretreated pregnant females .seem to have a slightly more active
reductase system present at birth.

Activity developed at a more rapid

rate in offspring from pretreated females as compared with controls
and offspring receiving phenobarbital through the mother's milk.
The mechanism by which structually unrelated drugs, carcinogenic
hydrocarbons, insecticides, and other compounds increase hepatic
microsomal enzyme activity has been the subject of intensive research
in recent years.

It has been demonstrated that phenobarbital,

chlordane, 3-methylcholanthrene, or 3 ,4-benzpyrene do not increase
the activity of drug metabolizing enzymes when added to in vitro
enzyme systems (5, 9, 10) .

Phenobarbital administration increases the

maximal velocity of ethylmorphine N-demethylation, chlorpromazine
sulfoxidation, and hexobarbital oxidation, but does not influence the

.21
Michaelis constants or the susceptibility of the enzyme system to
various inhibitors (22).

This indicates the increased activity of

hepatic microsomal enzymes from phenobarbital treated rats can not
be explained by an altered affinity of enzyme for substrate.
Several attempts to demonstrate that polycyclic hydrocarbons
or phenobarbital enhance drug metabolizing activity by increasing
the level of an inhibitor have been unsuccessful (5, 9,23).

The

discovery that certain compounds that inhibit the synthesis of protein
also prevent drug induced increas es in microsomal enzyme activity
indicates increases in activity are related to an increased synthesis
of enzyme protein.

The stimulation of enzyme activity present in

hepatic microsomes by 3-methylcholanthrene or phenobarbital is blocked
by ethionine (5,9,10,24), puromycin (25, 26) , or actinornycin D
(26, 27).

It has been reported that these inhibitors block protein

synthesis by different mechanisms.

Ethionine blocks protein synthesis

by lowering the level of ATP in the liver (28), puromycin blocks
the transfer of soluble RNA-bound amino acid into microsomal
protein (29) , and actinomycin D binds with DNA to block the
DNA-directed synthesis of nuclear RNA which is required for protein
synthesis (30).

The inhibitory effect of ethionine on liver protein

synthesis and the induction of increased drug metabolizing act-i vity
in hepatic microsomes can be prevented in vivo by the administration
of either ATP (28) or methionine (5, 9, 10).

This suggests that

adequate levels of S-adenosylmethionine may be important for the
synthesis of microsomal enzymes.

The blocking effect of

actinomycin D suggests that phenobarbital and 3-methylcholanthrene

22
may accelerate the DNA-directed synthesis of drug metabolizing
enzymes on ribosomes.

When puromycin, ethionine, or actinomycin D

is administered several hours after 3-methylcholanthrene further
increases in activity of aminoazo dye N-demethylase is prevented.
This mey indicate the formation of a short lived messenger-RNA
required for the increased synthesis of aminoazo dye N-demethylase
(24, 9).

Loeb and Gelboin (31) reported that treatment of rats with

3-methylcholanthrene increased the content of mess enger-RNA in
isolated liver nuclei and that nuclear RNA from treated rats was
more active than equivalent amounts of RNA from normal rats in
directing the incorporation of L-phenylalanine-c
in a cell free Escherichia coli system.

14

into protein

Jervell et al. (32)

confirmed the blocking action of ethionine, puromycin and
actinomycin D on the induction of aminoazo dye N-demethylas e by
3-methylcholanthrene, but reported the induction of this enzyme
by starvation is blocked by ethionine or puromycin but not by
actinomycin D.
mechanisms.

This suggests the involvement of two different

These authors also reported that i nduction of the

N-demethylase system was blocked by the administration of glucose
or fructose.
The possibility that inducers of hepatic microsomal enzymes
may increase activity by stabilizing enzymes , as well as by
accelerating their synthesis , is now being studied in several labora
tories.

Jick and S huster (3 3, 34) found that treatment of mice with

phenobarbital increas es liver microsomal TPNH-cytochrome c reductas e

levels by increas ing its rate of synthesis and decreasing its rate
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These two workers also reported that phenobarbital

of breakdown.

increases total li ver m i crosomal prote i n in rats by the same
Holtzman and G i llette (35) reported that phenobarbital

mechanism.

inhibits the degradation of hepatic microsomal phosphol i pid in
fasted rats.
Gelboin and Sokoloff (7) reported that the stimulatory effect
of phenobarbital and 3-methylcholanthrene on the synthesis of
microsomal enzymes and protein·· in vi vo is paralled by increased
incorporation of am i no acids

i nto

microsomal protein in v itro.

Phenobarbital produces a greater stimulation of amino acid
incorporation

i nto

m i crosomal prote i n than does 3-methylcholanthrene.

This agrees with the observat i on that phenobarbital stimulates
more synthesis of microsomal protein in vivo than 3-methyl c holanthrene
( 25).

Gelboi n and Sokolof f (7) also reported that 3-methylcholanthrene

stimulates the incorporation of soluble RNA-bound amino a�ids into
liver protein in vitro.

This indicates that it does not act on

reactions leading to activation of amino acids but on steps between
transfer-RNA and the formation of protein on ribosom es.

These

investigators suggest that the in c rease in amino acid incorporation
induced by 3-methylcholanthrene is due , at least in part, to an
in c rease in the number of active mi c rosomal incorporation sites
and an apparent increase in the messenger-RNA content of mi c rosomes .
Kato et al. (36) suggest that a portion of the greater amino . ac i d
in c orporating activity of microsomes from phenobarbital treated
rats may be

due

to a phenob arbital induced shift to a greater

proportion of membrane bound ribosomes .

Kato et al. ( 37) showed
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that treatment of rats with phenobarbital stimulates the incorporation
of

c14 -leucine

into microsomal protein in vivo but has no effect on

the incorporation of this amino acid into protein in other sub
cellular fractions.
Treatment of rats with phenobarbital increased by 108 to 266
per cent the incorporation of arginine, leucine , lysine , phenylalanine ,
and valine into liver microsomal protein in vitro.

This effect could

not be attributed to changes in cofactor level, amino acid con
centration, or factors present in the cell sap.

A fter the removal

of endogenous messenger-RNA by incubation of the microsomes, the
microsomes from phenobarbital treated rats displayed greater ability
·
14
to incorporate L-phenylalanine-C
in the presence of either
saturating or subsaturating amounts of polyuridylic acid .

The

ribosomes from phenobarbital treated and control rats have equal
ability to incorporate this amino acid.

This indicates that pheno

barbital stimulated increases in microsomal enzyme activity are not
directly related to alterations in the ribosomes, but suggests that it
alters the translation of polyuridylic acid on the ri bosomes (36).
The ability of several stimulators of liver microsomal enzy�e
activity to increase the concentrations of TPNH oxidase, TPNH
cytochrome c reductase, and cytochrome P-450 in liver microsomes
suggests that the induction of these electron transport . systems
may play a role in the stimulatory effect of these compounds.
This scheme is incomplete and cannot explain the selective effect
of enzyme inducers that stimulate some liver microsomal hydroxyla
tions without influencing others (1 ).
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The results of this study indicate that a significant increase in
acti vity of the hepatic microsomal enzyme system which reduces
p-nitrobenzoi c acid does not take place in offspring from sodium
phenobarbital pretreated pregnant rats until the fifth day after
delivery.

This may be due to the limited capabili ty of enzyme forming

systems at this stage of development.

It has been reported that the

transformati on of a normal li ver cell into a cancer cell is accompanied
by a decrease of drug metabolizing activity (38, 39).

It is of

interest that hepatomas that resemble normal liver hi stologically
and bi ochemically possess little or no microsomal drug metabolizing
activity ( 38 , 39, 40).

Low levels of activity are also present in

.regenerating liver (41, 42, 4 3).

The limited capability of fetal

and newborn (less than 5 days old) liver microsomal enzymes to be
stimu).ated may result from a short supply of cofactors or the incomplete
development of the endoplasmic reticulum or may involve other factors.
Little work has been done in this area of study and as a result no
comprehensive theory can be presented at this time.
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SUMMARY

The method reported by Fouts and Brodie (17 ) was used to

1.

determine the effect of sodium phenobarbital on the activity of the
liver microsomal enzyme system which reduces p-nitrobenzoic acid in
fetal and newborn rats.
2.

Sodium phenobarbital (30 mg./kg. ) was given twice daily

by subcutaneous inj ection to pregnant rats beginning approximately
five days before delivery and continuing throughout the experimental
period.
The liver microsomal enzyme system which reduces p-nitro

3.

benzoic acid developed at a more rapid rate and to a higher level of activity in offspring from pretreated females _ than in offspring
from controls.

4.

The slightly more active reductase present at birth and

the observation that offspring from pretreated pregnant rats
,.

develop activity faster than offspring given phenobarbital through
the milk may indicate that some activity was induced in the fetus.

5.

The liver microsomal enzyme system which reduces

p-nitrobenzoic acid is present in male and female rats at the
same level of activity before and after reaching maturity.

6.

The inductive effect of sodium pheno:b arbital ·o n the

enzyme system which reduce p-nitrobenzoic acid is the same in
male and female rats.

").,·-

I...
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